Your session is about to expire
← Back to Search
Behavioural Intervention
Tai Chi for Cancer Survivors
Phase < 1
Waitlist Available
Led By Ce Shang, PhD
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months post-intervention
Awards & highlights
No Placebo-Only Group
Summary
This trial looks at whether Tai Chi can help cancer survivors quit smoking. It is an ancient Chinese exercise that uses gentle movements, postures, and breathing to promote health. No meds or procedures involved.
Who is the study for?
This trial is for adult cancer survivors (21+ years old) who finished treatment at least 3 months ago and are current smokers with a moderate interest in quitting. They must be able to join Zoom calls. People not eligible include those treated for cancer within the last 3 months, under 21, unable to use Zoom, or have low interest in stopping smoking.
What is being tested?
The study tests an online Tai Chi program designed to help cancer survivors quit smoking. It includes slow movements, posture exercises, meditation, and controlled breathing without medications or medical procedures. Participants will also undergo carbon monoxide measurement and surveys.
What are the potential side effects?
Since Tai Chi is a non-invasive exercise with meditative aspects, it typically does not cause severe side effects. However, participants may experience mild discomfort like muscle soreness or fatigue from the physical activity.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 6 months post-intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months post-intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
CO verification
Cigarette Dependence Scale (12 item)
Hospital Anxiety and Depression Scale
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (Tai Chi)Experimental Treatment6 Interventions
Participants receive access to the online WaQi program to practice Tai Chi supervised and home-based over 8 weeks. Participants also receive standard cessation treatment that includes a prescription or recommendation for NRT and CO testing on study.
Group II: Arm II (Standard cessation)Active Control6 Interventions
Participants receive standard cessation treatment that includes a prescription or recommendation for NRT and undergo CO testing on study. Participants also receive an 8-week online Tai Chi self-administered teaching module subscription at the end of the study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nicotine Replacement
2019
Completed Phase 2
~420
Find a Location
Who is running the clinical trial?
Ohio State University Comprehensive Cancer CenterLead Sponsor
340 Previous Clinical Trials
293,262 Total Patients Enrolled
Ce Shang, PhDPrincipal InvestigatorOhio State University Comprehensive Cancer Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 21 years old or older.I am a cancer patient who hasn't been treated or was last treated within 3 months.I am younger than 21 years old.I can join Zoom calls for meetings and treatments.I finished my cancer treatment at least 3 months ago.
Research Study Groups:
This trial has the following groups:- Group 1: Arm I (Tai Chi)
- Group 2: Arm II (Standard cessation)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.